- Cosmeceutics - Anti aging products
- 毛发移植或修复仪器和设备
- Active pharmaceutical ingredient manufacturer
“The first RNAi tech-driven Androgenetic Alopecia solution for both women and men” CosmeRNA ARI. SAMiRNA-AR68 is specifically designed to selectively inhibit the expression of AR in hair follicle cells, which causes or exacerbates androgenetic alopecia, and it has been proven safe and effective through clinical trials.
SAMiRNA stands as an innovative siRNA delivery platform applied to CosmeRNA ARI, utilizing nanoparticle vectors to efficiently deliver therapeutic genes.
Since 1992, the developer and manufacturer of this innovative product, Bioneer, has been dedicated to DNA & RNA R&D based on four Nobel Prize-awarded core technologies in the field of life sciences, including DNA sequencing, DNA synthesis, PCR, and siRNA.
Bioneer is now positioned to fully integrate its capability to develop next-generation technologies in the post-genome era through the invention of new biochemistry and instruments. Bioneer now operates 2 production & research facilities in Korea.